Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: Biomed Pharmacother. 2017 Feb 24;89:268–275. doi: 10.1016/j.biopha.2017.01.144

Table 2.

Tumor-to-muscle ratios, from biodistribution and scintigraphic images, achieved after intravenous injection of 99mTc-DTPA-PM in 4T1 tumor-bearing mice.

Time (h)

1 4 8 24
Scintigraphic images 2.4 ± 0.2 2.8 ± 0.3 3.3 ± 0.4a 2.8 ± 0.3
Biodistribution 1.9 ± 0.2b 2.7 ± 0.4b 2.5 ± 0.8b 5.0 ± 1.3

Data are expressed as the mean ± the standard deviation of the mean (n = 6).

a

Represents significant difference when compared with tumor-to-muscle ratio at 1 h post-injection.

b

Represents significant difference when compared with tumor-to-muscle ratio at 24 h post-injection.